TypeZero

Dexcom talks $11.3M TypeZero acquisition, new FDA clearances on Q3 earnings call
By Jonah Comstock | 03:42 pm | November 15, 2018
While the company's successful G6 launch was its focus, Dexcom had a busy third quarter for other news as well.